Agilent Technologies announces new multiplexing capability in SureSelect Target Enrichment System

NewsGuard 100/100 Score

Agilent Technologies Inc. (NYSE:A) today announced that its Agilent SureSelect Target Enrichment System supports multiplexed DNA sequencing of 12 to 16 samples per lane depending on the next-generation sequencing platform, reducing costs and increasing throughput up to 16-fold.

“Agilent SureSelect’s new multiplexing capability extends this benefit by dramatically reducing costs and significantly increasing throughput without sacrificing data quality.”

“We originally designed the Agilent SureSelect Target Enrichment System to enable geneticists to efficiently analyze larger numbers of samples by sequencing just the genomic regions of interest,” said Fred Ernani, Ph.D., Agilent marketing manager, Emerging Genomic Applications. “Agilent SureSelect’s new multiplexing capability extends this benefit by dramatically reducing costs and significantly increasing throughput without sacrificing data quality.”

Protocols are robust and easy to follow, enabling multiple samples to be run together, but their data to be analyzed separately. The kits are optimized for the Illumina Genome Analyzer and the Applied Biosystems SOLiD platform. The Illumina can sequence 12 samples per lane for a total of 96 samples per run. The SOLiD platform can sequence 16 samples per quadrant or octet, allowing up to 256 samples to be processed per run.

The first Agilent SureSelect products available with multiplexing capabilities are custom kits designed with eArray; Agilent’s Web-based microarray and the Agilent SureSelect design tool. The kits are packaged in a variety of sizes, ranging from 10 to 5,000 reactions per custom kit. Having kits of different sizes allows researchers to use the same technology for small initial investigations as well as large profiling studies, all with the same product format that is amenable to automation. New kits composed of predefined content will be available in multiplexing format later this year.

“Several customers are testing Agilent SureSelect products supporting indexing and barcoding, and are pleased with the performance they are getting,” said Ernani.

The Agilent SureSelect Target Enrichment System, employing a method licensed from the Broad Institute of Harvard and MIT, is now the platform with the most optimized protocols for a diverse set of sequencing protocols and platforms. It supports Illumina end-sequencing and paired-end sequencing protocols in addition to fragment library format sequencing on the SOLiD System. Users of Agilent’s eArray online design tool can improve the efficiency of their research by easily designing custom products to target any genome of interest, all in a single tube.

SOURCE Agilent Technologies Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
DNA repair process key to memory formation, study finds